Development validation and applications of the monocyte activation test for pyrogens based on human whole blood

Altex

Volumn 26, Issue 4, 2009, Pages 265-277

  Schindler, Stefanie ^a,c   Von Aulock, Sonja ^a   Daneshian, Mardas ^a   Hartung, Thomas ^a,b  

^a UNIVERSITY OF KONSTANZ   (Germany)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c Foundation Animalfree Research   (Switzerland)

Author keywords

Alternatives to animals; Interleukin 1 ; Monocyte activation test; Validation study

Indexed keywords

PYROGEN; DRUG;

AIR QUALITY; BLOOD SAMPLING; CELL ACTIVATION; DIALYSIS; EXPERIMENTAL RABBIT; FEVER; FOOD AND DRUG ADMINISTRATION; IN VITRO STUDY; LABORATORY TEST; LIMULUS AMOEBOCYTE LYSATE; MEDICAL INSTRUMENTATION; MEDICAL LITERATURE; MONOCYTE; NONHUMAN; REVIEW; ANALYTICAL EQUIPMENT; ANIMAL; ANIMAL TESTING ALTERNATIVE; ARTICLE; BACTERIUM; BLOOD; CRYOPRESERVATION; DRUG EFFECT; EVALUATION; HUMAN; METABOLISM; RABBIT; REPRODUCIBILITY;

ANIMAL TESTING ALTERNATIVES; ANIMALS; BACTERIA; BLOOD; CRYOPRESERVATION; HUMANS; MONOCYTES; PHARMACEUTICAL PREPARATIONS; PYROGENS; RABBITS; REAGENT KITS, DIAGNOSTIC; REPRODUCIBILITY OF RESULTS;

EID: 79952198005     PISSN: 09467785     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (119)

1. Amato, R. L. (2002). The link between dialysate and chronic inflammatory disease in hemodialysis. Nephrol. Nurs. J. 29, 490-4922.
2. Anderson, J. M. and Miller, K. M. (1984). Biomaterials biocompatibility and the macrophage. Biomaterials 5, 5-10.
3. Arvanitidou, M., Spaia, S., Katsinas, C. et al. (1998). Microbiological quality of water and dialysate in all haemodialysis centres of Greece. Nephrol. Dial. Transplant. 13, 949-954.
4. Association for the Advancement of Medical Instrumentation (2001). AAMI Standards and Recommended Practices, vol. 3 (1-332). Arlington: American National Standards Institute.
5. Atkins, E. and Morse, S. I. (1967). Studies in staphylococcal fever. VI. Responses induced by cell walls and various fractions of staphylococci and their products. Yale J. Biol. Med. 39, 297-311.
6. Atkins, E. and Huang, W. C. (1958). Studies on the pathogenesis of fever with influenza virus. I. The appearance of an endogenous pyrogen in the blood following intravenous injection of virus. J. Exp. Med. 107, 383-401.
7. Bambauer, R., Schauer, M., Jung, W. K. et al. (1994). Contamination of dialysis water and dialysate. A survey of 30 centers. ASAIO J. 40, 1012-1016.
8. Baz, M., Durand, C., Ragon, A. et al. (1991). Using ultrapure water in hemodialysis delays carpal tunnel syndrome. Int. J. Artif. Organs 14, 681-685.
9. Beeson, P. B. (1948). Temperature-elevating effect of a substance obtained from Polymorphonuclear leucocytes. J. Clin. Invest. 27, 524.
10. Bennett, I. L. and Beeson, P. B. (1953). Studies on the pathogenesis of fever. II. Characterization of fever-producing substances from polymorphonuclear leukocytes and from the fluid of sterile eluates. J. Exp. Med. 98, 493-508.
11. Blajchman, M. A., Beckers, E. A., Dickmeiss, E. et al. (2005). Bacterial detection of platelets: Current problems and possible resolutions. Transfus. Med. Rev. 19, 259-272.
12. Bodel, P. T. and Atkins, E. (1965). Studies in staphylococcal fever. V. Staphylococcal filtrate pyrogen. Yale J. Biol. Med. 38, 282-298.
13. Brandenburg, K., Howe, J., Gutsman, T. and Garidel, P. (2009). The expression of endotoxic activity in the Limulus test as compared to cytokine production in immune cells. Curr. Med. Chem. 16, 2653-2660.
14. Braude, A. I., McConnell, J. and Douglas, H. (1960). Fever from pathogenic fungi. J. Clin. Invest. 39, 1266-1276.
15. Brunson, K. W. and Watson, D. W. (1974). Pyrogenic specificity of streptococcal exotoxins, staphylococcal enterotoxin, and gram-negative endotoxin. Infect. Immun. 10, 347-351.
16. Carlin, G. and Viitanen, E. (2005). In vitro pyrogenicity of the diphtheria, tetanus and acellular pertussis components of a trivalent vaccine. Vaccine 23, 3709-3715.
17. Carlin, G. and Viitanen, E. (2003). In vitro pyrogenicity of a multivalent vaccine: Infanrix. PharmEuropa 15, 418-423.
18. Cinkotai, F. F., Lockwood, M. G. and Rylander, R. (1977). Airborne micro-organisms and prevalence of byssinotic symptoms in cotton mills. Am. Ind. Hyg. Assoc. J. 38, 554-559.
19. Daneshian, M., von Aulock, S. and Hartung, T. (2009). Assessment of pyrogenic contaminations with the validated human whole blood assay. Nature Protocols 12, 1709-1721.
20. Daneshian, M., Wendel, A., Hartung, T. and von Aulock, S. (2008). High sensitivity pyrogen testing in water and dialysis Solutions. J. Immunol. Meth. 336, 64-70.
21. Daneshian, M., Guenther, A., Wendel, A. et al. (2006). In vitro pyrogen test for toxic or immunomodulatory drugs. J. Immunol. Meth. 313, 169-175.
22. De Boer, M., Reijneke, R., Van de Griend, R. J. et al. (1981). Large-scale purification and cryopreservation of human monocytes. J. Immunol. Methods 43, 225-239. (Pubitemid 11112517)
23. Dehus, O., Hartung, T. and Hermann, C. (2006). Endotoxin evaluation of eleven lipopolysaccharides by whole blood assay does not always correlate with Limulus amebocyte lysate assay. J. Endotoxin Res. 12, 171-180. (Pubitemid 47487522)
24. Deininger, S., Traub, S., Aichele, D. et al. (2008). Presentation of lipoteichoic acid potentiates its inflammatory activity. Immunobiol. 213, 519-529.
25. Dinarello, C. A. (2004). Infection, fever, and exogenous and endogenous pyrogens: some concepts have changed. J. Endotoxin Res. 10, 201-222.
26. Dinarello, C. A., Koch, K. M. and Shaldon, S. (1999). Interleukin-1 and its relevance in patients treated with hemodialysis. Kidney Int. 33, 21-26.
27. Dinarello, C. A., Cannon, J. G., Mancilla, J. et al. (1991). Interleukin-6 as an endogenous pyrogen: induction of prostaglandin E2 in brain but not in peripheral blood mononuclear cells. Brain Res. 562, 199-206.
28. Dinarello, C. A., Cannon, J. G., Wolff, S. M. et al. (1986). Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin-1. J. Exp. Med. 163, 1433-1450.
29. Dinarello, C. A., Koch, K. M. and Shaldon, S. (1988). Interleukin-1 and its relevance in patients treated with hemodialysis. Kidney Int. Suppl. 24, 21-26.
30. Dinarello, C. A., Goldin, N. P. and Wolff, S. M. (1974). Demonstration and characterization of two distinct human leukocytic pyrogens. J. Exp. Med. 139, 1369-1381.
31. Draing, C., Sigel, S., Deininger, S. et al. (2008). Cytokine induction by Gram-positive bacteria. Immunobiol. 213, 285-296.
32. Donham, K. J., Zavala, D. C. and Merchant, J. A. (1984a). Acute effects of the work environment on pulmonary functions of swine confinement workers. Am. J. Ind. Med. 5, 367-375.
33. Donham, K. J., Zavala, D. C. and Merchant, J. A. (1984b). Respiratory symptoms and lung function among workers in swine confinement buildings: a cross-sectional epidemiological study. Arch. Environ. Health 39, 96-101.
34. Emancipator, K., Csako, G. and Elin, R. J. (1992). In vitro inactivation of bacterial endotoxin by human lipoproteins and apolipoproteins. Infect. Immun. 60, 596-601.
35. Eperon, S. and Jungi, T. W. (1996). The use of human monocytoid lines as indicators of endotoxin. J. Immunol. Methods 194, 121-129.
36. Evans, R. C. and Holmes, C. J. (1991). In vitro study of the transfer of cytokine-inducing substances across selected high-flux hemodialysis membranes. Blood Purif. 9, 92-101.
37. Favero, M. S., Petersen, N. J., Boyer, K. M. et al. (1974). Microbial contamination of renal dialysis systems and associated health risks. Trans. Am. Soc. Artif. Intern. Organs 20A, 175-183.
38. Fennrich, S., Fischer, M., Hartung, T. et al. (1999). Detection of endotoxins and other pyrogens using human whole blood. Dev. Biol. Stand 101, 131-139.
39. Fischer, M., Keller-Stanislawski, B., Schober-Bendixen, S. et al. (2001). Effect of the preservative thiomersal on the release of interleukin-1 beta from human peripheral blood cells. ALTEX 18, 47-49.
40. Grätsch, W., Leimbach, R. and Sonnenschein, B. (1992). On the safety of medical products: The detection of endotoxin on sterile surgical gloves. Hyg. Med. 17, 200-206.
41. Grötsch, W. and Eibach, F. (1990). Pyrogenprüfung von Verbandstoffen und verwandten Medicalprodukten. Hyg. Med. 15, 45-54.
42. Hartung, T. (2008). Food for thought ... on animal tests. ALTEX 25, 3-9.
43. Hartung, T., Aaberge, I., Berthold, S. et al. (2001). Novel pyrogen tests based on the human fever reaction. The report and recommendations of ECVAM workshop 43. ATLA 29, 99-123.
44. Hartung, T. (2002). Comparison and validation of novel pyrogen tests based on the human fever reaction. ATLA 30 Suppl. 2, 49-51.
45. Hartung, T., Fennrich, S., Fischer, M. et al. (2000). Prevalidation of an alternative to the rabbit pyrogen test based on human whole blood. In M. Balls, A. M. van Zeller and M. E. Haider (eds.), Progress in the Reduction, Refinement and Replacement of Animal Experimentation (991-999). Amsterdam, The Netherlands: Elsevier Science B. V.
46. Hartung, T. and Wendel, A. (1995). Detection of Pyrogens using human whole blood. ALTEX 12, 70-75.
47. Hasiwa, M., Kullmann, K., von Aulock, S. et al. (2007). An in vitro pyrogen safety test for immune-stimulating components on surfaces. Biomaterials 28, 1367-1375. (Pubitemid 46001463)
48. Hoffmann, S., Peterbauer, A., Schindler, S. et al. (2005a). International validation of novel pyrogen tests based on human monocytoid cells. J. Immunol. Methods 298, 161-173. (Pubitemid 40545102)
49. Hoffmann, S., Luederitz-Puechel, U., Montag-Lessing, T. and Hartung, T. (2005b). Optimisation of pyrogen testing in parenterals according to different pharmacopoeias by probabilistic modelling. J. Endotoxin Res. 11, 25-31. (Pubitemid 40533076)
50. Hurton, L., Berkson, J. and Smith, S. (2009). Biology and Conservation of Horseshoe Crabs. The Effect of Hemolymph Extraction Volume and Handling Stress on Horseshoe Crab Mortality (331-346). Heidelberg, Springer-Verlag GmbH.
51. Kindinger, I., Daneshian, M., Baur, H. et al. (2005). A new method to measure air-borne pyrogens based on human whole blood cytokine response. J. Immunol. Methods 298, 143-153. (Pubitemid 40545100)
52. Klein, E., Pass, T., Harding, G. B. et al. (1990). Microbial and endotoxin contamination in water and dialysate in the central United States. Artif. Organs 14, 85-94. (Pubitemid 20140767)
53. Kobayashi, G. S. and Friedman, L. (1964). Characterization of the pyrogenicity of Candida albicans, saccharomyces cervisiae, and cryptococcus neoformans. J. Bacterial. 88, 660-666.
54. Kuehnert, M. J., Roth, V. R., Haley, N. R. et al. (2001). Transfusion-transmitted bacterial infection in the United States, 1998 through 2000. Transfusion 41, 1493-1499. (Pubitemid 34072672)
55. Kulander, L., Nisbeth, U., Danielsson, B. G. and Eriksson, O. (1993). Occurrence of endotoxin in dialysis fluid from 39 dialysis units. J. Hosp. Infect. 24, 29-37.
56. Kullmann, K. (2002). Adaption des In Vitro Pyrogen Tests (IPT) für prothetische Materialien, Master Thesis, Fachbereich Biologie der Universität Konstanz, Germany.
57. Kure, R., Grendahl, H. and Paulssen, J. (1982). Pyrogens from surgeons' sterile latex gloves. Acta Pathol. Microbiol. Immunol. Scand. [B] 90, 85-88.
58. Laburn, H. P., Rosendorff, C., Willies, G. and Woolf, C. (1974). Proceedings: A role for noradrenaline and cyclic AMP in prostaglandin E1 fever. J. Physiol. 240, 49P-50P.
59. Laurence, R. A. and Lapierre, S. T. (1995). Quality of hemodialysis water: a 7-year multicenter study. Am. J. Kidney Dis. 25, 738-750.
60. Levin, J. and Bang, F. B. (1964a). A description of cellular coagulation in the limulus. Bull. Johns Hopkins Hosp. 115, 337-345.
61. Levin, J. and Bang, F. B. (1964b). The role of endotoxin in the extracellular coagulation of limulus blood. Bull. Johns Hopkins Hosp. 115, 265-274.
62. Li, S., Goorha, S., Ballou, L. R. and Blatteis, C. M. (2003). Intracerebroventricular interleukin-6, macrophage inflammatory protein-1 beta and IL-18: pyrogenic and PGE2-mediated? Brain Res. 992, 76-84.
63. Li, S., Ballou, L. R., Morham, S. G. and Blatteis, C. M. (2001). Cyclooxygenase-2 mediates the febrile response of mice to interleukin-1beta. Brain Res. 910, 163-173.
64. Li, S., Wang, Y., Matsumura, K. et al. (1999). The febrile response to lipopolysaccharide is blocked in cyclooxygenase-2(-/-), but not in cyclooxygenase-1(-/-) mice. Brain Res. 825, 86-94. (Pubitemid 29222865)
65. Liebers, V., Stubel, H., Düser M. et al. (2009). Standardization of whole blood assay for determination of pyrogenic activity in organic dust samples. Int. J. Hygiene Env. Health 212, 547-556.
66. Lonnemann, G., Behme, T. C., Lenzner, B. et al. (1992). Permeability of dialyzer membranes to TNF alpha-inducing substances derived from water bacteria. Kidney Int. 42, 61-68.
67. Marion-Ferey, K., Leid, J. G., Bouvier, G. et al. (2005). Endotoxin level measurement in hemodialysis biofilm using "the whole blood assay". Artif. Organs 29, 475-481.
68. Mazzotti, F., Beuttler, J., Zeller, R. et al. (2007). In vitro pyrogen test - a new test method for solid medical devices. J. Biomed. Mater Res. 80, 276-282.
69. McClosky, W. T., Price, C. W., van Winkle, W. J. et al. (1943). Results of the first USP collaborative study of pyrogens. J. Am. Pharm. Assoc. 32, 69-73.
70. McDonald, C. P., Hartley, S., Orchard, K. et al. (1998). Fatal Clostridium perfringens sepsis from a pooled platelet transfusion. Transfus. Med. 8, 19-22.
71. Mitzner, S., Stange, J., Pichel, K. et al. (1995). Increased soluble CD14 levels in patients on hemodialysis. Influence of dialysate endotoxin or incompatibility to dialyzer membranes? ASAIO J 41, M707-708.
72. Miyasaka, N., Sato, K., Kitano, Y. et al. (1992). Aberrant cytokine production from tenosynovium in dialysis associated amyloidosis. Ann. Rheum. Dis. 51, 797-802.
73. Mohr, L. C. (2004). Hypersensitivity pneumonitis. Curr. Opin. Pulm. Med. 10, 401-411.
74. Morath, S., Geyer, A., Spreitzer, I. et al. (2002). Structural decomposition and heterogeneity of commercial lipoteichoic acid preparation. Infect. Immun. 70, 938-944.
75. Morath, S., Geyer, A. and Hartung, T. (2001). Structure-function relationship of cytokine induction by lipotechoic acid from Staphylococcus aureus. J. Exp. Med. 193, 393-398.
76. Neal, P. A., Schneiter, R. and Caminita, B. H. (1942). Report on acute illness among rural mattress makers using low grade, stained cotton. JAMA 119, 1074-1082.
77. Pegues, D. A., Oettinger, C. W., Bland, L. A. et al. (1992). A prospective study of pyrogenic reactions in hemodialysis patients using bicarbonate dialysis fluids filtered to remove bacteria and endotoxin. J. Am. Soc. Nephrol. 3, 1002-1007.
78. Perez, P., Salmi, R., Folléa, G. et al. (2001). Determinants of transfusion-associated bacterial contamination: results of the French BACTHEM case-control study. Transfusion 41, 862-871.
79. Peterbauer, A. and Werner-Felmayer, G. (1999). Further development of a cell culture model for the detection of bacterial pyrogens. ALTEX 16, 3-8.
80. Phillips, G., Hudson, S. and Stewart, W. K. (1994). Persistence of microflora in biofilm within fluid pathways of contemporary haemodialysis monitors (Gambro AK-10). J. Hosp. Infect. 27, 117-125.
81. Pool, E. J., Johaar, G., James, S. et al. (1998). The detection of pyrogens in blood products using an ex vivo whole blood culture assay. J. Immunoassay 19, 95-111. (Pubitemid 28340852)
82. Poole, S., Dawson, P. and Gaines Das, R. E. (1997). Second international standard for endotoxin: calibration in an international collaborative study. J. Endotoxin Res. 4, 221-231. (Pubitemid 27356300)
83. Prausnitz, C. (1936). Investigations on respiratory dust disease in operatives in the cotton industry. Medical Research Council, Special report series 212, 1-73, His Majesty's Stationery Office, London.
84. Raij, L., Shapiro, F. L. and Michael, A. F. (1973). Endotoxemia in febrile reactions during hemodialysis. Kidney Int. 4, 57-60.
85. Rich, A. and Harris, A. K. (1981). Anomalous preference of cultured macrophages for hydrophobic and roughened substrata. J. Cell Sci. 50, 1-7.
86. Rietschel, E. T., Kirikae, T., Schade, F. U. et al. (1993). The chemical structure of bacterial endotoxin in relation to bioactivity. Immunobiol. 187, 169-190. (Pubitemid 23150766)
87. Refai, A. K., Textor, M., Brunette, D. M. and Waterfield, J. D. (2004). Effect of titanium surface topography on macrophage activation and secretion of proinflammatory cytokines and chemokines. J. Biomed. Res. 70A, 194-205.
88. Rosenberg, S. A. (2001). Cellular therapy: an introduction. Cancer J. 7 Suppl. 2, 51-52.
89. Rotta, J. (1975). Endotoxin-like properties of the peptidoglycan. Z. Immunitätsforsch. Exp. Klin. Immunol. 149, 230-244.
90. Rudloe, A. and Hernkind, A. E. (1983).The effect of heavy bleeding on mortality of the horseshoe crab, Limulus polyphemus, in the natural environment. J. Invertebr. Pathol. 42, 167-176.
91. Schindler, S., Spreitzer, I., Loschner, B. et al. (2006a). International validation of pyrogen tests based on cryopreserved human primary blood cells. J. Immunol. Meth. 316, 42-51.
92. Schindler, S., Rosenberg, U., Schlote, D. et al. (2006b). Pyrogen testing of lipidic parenterals with a novel in vitro test. PharmEuropa Sci. Notes, 1-7.
93. Schindler, S., Asmus, S., von Aulock, S. et al. (2004). Cryopreservation of human whole blood for pyrogenicity testing. J. Immunol. Meth. 294, 89-100.
94. Schindler, S., Bristow, A., Cartmell, T. et al. (2003). Comparison of the reactivity of human and rabbit blood towards pyrogenic stimuli. ALTEX 20, 59-63.
95. Schleifer, K. H. (1975). Chemical structure of the peptidoglycan, its modifiability and relation to the biological activity. Z. Immunitätsforsch. Exp. Klin. Immunol. 149, 104-117.
96. Schouten, W. E., Grooteman, M. P., van Houte, A. J. et al. (2000). Effects of dialyser and dialysate on the acute phase reaction in clinical bicarbonate dialysis. Nephrol. Dial. Transplant. 15, 379-384.
97. Schwalbe, S., Holzhauer, M., Schaeffer, J. et al. (1997). Beta 2-microglobulin associated amyloidosis: a vanishing complication of long-term hemodialysis. Kidney Int. 52, 1077-1083.
98. Shmunes, E. and Darby, T. (1984). Contact dermatitis due to endotoxin in irradiated latex gloves. Contact Dermatitis 10, 240-244. (Pubitemid 14132566)
99. Soskolne, W. A., Cohen, S., Sennerby, L. et al. (2002). The effect of titanium surface roughness on the adhesion of monocytes and their secretion of TNF-α and PGE2. Clin. Oral Implants Res. 13, 86-93.
100. Spreitzer, I., Löschner, B., Schneider, C. K. et al. (2007). 10 years of experience with alternative pyrogen tests (monocyte activation tests). AATEX 14 Spec. Issue, 587-589. Proc. 6th World Congress on Alternatives & Animal Use in the Life Sciences August 21-25, 2007, Tokyo, Japan.
101. Spreitzer, I., Fischer, M., Hartzsch, K. et al. (2002). Comparative study of rabbit pyrogen test and human whole blood assay on human serum albumin. ALTEX 19 Suppl. 1, 73-75.
102. Steere, A. C., Rifaat, M. K., Seligmann, E. B. et al. (1978). Pyrogen reactions associated with the infusion of normal serum albumin (human). Transfusion 18, 102-107. (Pubitemid 8326293)
103. Stoddard, M. B., Pinto, V., Keiser, P. B. and Zollinger, W. (2009). Evaluation of a Whole Blood Cytokine Release Assay for Use in Measuring Endotoxin Activity of Group B Neisseria meningitidis Vaccines Made from Lipid AAcylation Mutants. Clin. Vaccine Immunol, published online ahead of print on 18 November 2009.
104. Tranaeus, A. and Yao, Q. (2008). Immune dysfunction in dialysis patients - prevention and treatment strategies. Perit. Dial. Int. 28 Suppl. 3, S161-166.
105. Thelin, A., Tegler, O. and Rylander, R. (1984). Lung reactions during poultry handling related to dust and bacterial endotoxin levels. Eur. J. Respir. Dis. 65, 266-271.
106. Thompson, M. (1998). Assessments of the population biology and critical habitat for the horseshoe crab, Limulus polyphemus, in the South Atlantic Bight. Master's thesis 1998, Medical University of South Carolina, University of Charleston.
107. Tsuchida, K., Takemoto, Y., Yamagami, S. et al. (1997). Detection of peptidoglycan and endotoxin in dialysate, using silkworm larvae plasma and limulus amebocyte lysate methods. Nephron 75, 438-443. (Pubitemid 27156738)
108. Urena, P., Herbelin, A., Zingraff, J. et al. (1992). Permeability of cellulosic and non-cellulosic membranes to endotoxin subunits and cytokine production during in vitro haemodialysis. Nephrol. Dial. Transplant. 7, 16-28.
109. Ushikubi, F., Segi, E., Sugimoto, Y. et al. (1998). Impaired febrile response in mice lacking the prostaglandin E receptor subtype EP3. Nature 395, 281-284. (Pubitemid 28447553)
110. Walls, E. A. and Berkson, J. (2003). Effects of blood extraction on horseshoe crabs (Limulus polyphemus). Fish Bull 101, 457-459. (Pubitemid 36684377)
111. Ward, R. A. (2004). Ultrapure dialysate. Semin. Dial. 17, 489-497.
112. Watson, D. W. (1960). Host-parasite factors in group A streptococcal infections: pyrogenic and other effects of immunologic distinct exotoxins related to scarlet fever toxins. J. Exp. Med. 111, 255-284.
113. Welsh, H., Calvery, H. O., McClosky, W. T. and Price, C. W. (1943). Method of Preparation and Test for Bacterial Pyrogen. J. Am. Pharm. Assoc. 3, 65-69.
114. Werner, L., Tetz, M., Mentak, K. et al. (2009). Detection of pyrogens adsorbed to intraocular lenses - Evaluation of limulus amoebocyte lysate and in vitro pyrogen tests. Journal Cataract & Refract Surg. 35, 1273-1280.
115. Werner-Felmayer, G., Baier-Bitterlich, G., Fuchs, D. et al. (1995). Detection of Bacterial Pyrogens on the Basis of their Effects on Gamma Interferon-Mediated Formation of Neopterin or Nitrite in Cultured Monocyte Cell Lines. Clin. Diagn. Lab. Immunol. 2, 307-313.
116. Wollowitz, S. (2001). Fundamentals of the psoralen-based Helinx technology for inactivation of infectious pathogens and leukocytes in platelets and plasma. Semin. Hematol. 38 Suppl. 11, 4-11.
117. Ziats, N. P., Miller, K. M. and Anderson, J. M. (1988). In vitro and in vivo interactions of cells with biomaterials. Biomaterials 9, 5-13.
118. Zimmermann. M., Busch, K., Kuhn, S. and Zeppezauer, M. (1999). Endotoxin adsorbent based on immobilized human serum albumin. Clin. Chem. Lab. Med. 37, 373-379
119. Zucker, B. A., Draz, A. and Müller, W. (2000). Comparison of filtration and impingement for sampling airborne endotoxin. J. Aerosol. Sci. 31, 751-755.